1. Home
  2. GBIO vs TRVG Comparison

GBIO vs TRVG Comparison

Compare GBIO & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.59

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.90

Market Cap

278.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBIO
TRVG
Founded
2016
2005
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
278.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GBIO
TRVG
Price
$5.59
$2.90
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
$8.88
$3.96
AVG Volume (30 Days)
56.7K
55.4K
Earning Date
11-05-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,270,000.00
$614,486,683.00
Revenue This Year
N/A
$18.36
Revenue Next Year
N/A
$9.18
P/E Ratio
N/A
$97.79
Revenue Growth
N/A
14.41
52 Week Low
$3.00
$2.16
52 Week High
$12.40
$5.83

Technical Indicators

Market Signals
Indicator
GBIO
TRVG
Relative Strength Index (RSI) 56.71 46.39
Support Level $5.20 $2.81
Resistance Level $5.70 $3.15
Average True Range (ATR) 0.23 0.12
MACD 0.04 -0.00
Stochastic Oscillator 73.58 27.26

Price Performance

Historical Comparison
GBIO
TRVG

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

Share on Social Networks: